2020
DOI: 10.1002/ejhf.2056
|View full text |Cite
|
Sign up to set email alerts
|

First‐in‐man case of non‐invasive proton radiotherapy for the treatment of refractory ventricular tachycardia in advanced heart failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
13
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 22 publications
(16 citation statements)
references
References 6 publications
2
13
0
1
Order By: Relevance
“…Limited data are available on malfunctions during proton and carbon ion therapy 26,27 . In fact, the first use of proton therapy in a patient with ventricular tachycardia at the Centro Nazionale di Adroterapia Oncologica in Pavia/Italy was reported recently 28 . Thus, no consensus may have been reached because two complex issues were combined in one statement.…”
Section: Discussionmentioning
confidence: 99%
“…Limited data are available on malfunctions during proton and carbon ion therapy 26,27 . In fact, the first use of proton therapy in a patient with ventricular tachycardia at the Centro Nazionale di Adroterapia Oncologica in Pavia/Italy was reported recently 28 . Thus, no consensus may have been reached because two complex issues were combined in one statement.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, a precise gating or tracking could be done without the need and limitations of a fiducial marker. This could further reduce the safety margins to be applied and perhaps reduce treatment times, particularly in case of respiratory gated delivery for radiotherapy with heavy particles such as protons and carbon ions ( 9 , 10 , 12 , 20 ). A further usefulness of this system could consist in increasing the safety in the treatment phase, by controlling in real time the cardiac cycle and heart movements and allowing to interrupt the delivery of the radiant beam in case of anomalies on each of these two factors with extremely short reaction times.…”
Section: Discussionmentioning
confidence: 99%
“…To achieve this, the plan was normalized so that PTV D92% = 25 CGyE. Also, in order to arrive at a satisfactory treatment plan ( 26 , 27 ), robust optimization with 2 mm set-up error in all directions and 2% range uncertainty was used during planning.…”
Section: Case Descriptionmentioning
confidence: 99%